1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
(
- Contribution to journal › Article
- 2023
-
Mark
Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
(
- Contribution to journal › Article
-
Mark
Quantification of [18F]florbetaben amyloid-PET imaging in a mixed memory clinic population : The ABIDE project
(
- Contribution to journal › Article
-
Mark
Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAART
(
- Contribution to journal › Article
- 2022
-
Mark
The natural history of primary progressive aphasia : beyond aphasia
(
- Contribution to journal › Article
- 2021
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
(
- Contribution to journal › Article
-
Mark
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Association of amyloid-β CSF/PET discordance and tau load 5 years later
(
- Contribution to journal › Article
-
Mark
Amyloid-β PET and CSF in an autopsy-confirmed cohort
(
- Contribution to journal › Article
-
Mark
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
(
- Contribution to journal › Article